Last edition
News about "stage 3 colon cancer"
Roche's Tecentriq Wins US FDA Approval for Stage 3 Colon Cancer
The US FDA has approved Roche’s Tecentriq in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage 3 colon cancer.
Stage 3 Colon Cancer | 13/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members